Article Text

Download PDFPDF
Anakinra for systemic juvenile idiopathic arthritis

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Systemic juvenile idiopathic arthritis (JIA) constitutes about 10% of cases of childhood-onset idiopathic chronic arthritis. Chronic arthritis develops in up to 50% of cases and conventional disease-modifying antirheumatic drugs (DMARDs) such as methotrexate and tumour necrosis factor inhibitors may be relatively ineffective. Prolonged steroid treatment may be needed with consequent risk of osteoporosis, fractures and small stature. Up to 75% of patients may need joint replacement as adults. New treatments …

View Full Text


  • Competing interests None.

  • Provenance and peer review Commissioned; internally peer reviewed.